Global Parkinson Disease Drug Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Parkinson Disease Drug market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Parkinson Disease Drug market are covered in Chapter 9:
Lundbeck A/S
ACADIA Pharmaceuticals Inc.
Sanofi S.A.
Medtronic plc
Teva Pharmaceutical Industries Ltd.
Novartis AG
Merck & Co., Inc.
Homann-La Roche Ltd
Vertical Pharmaceuticals, LLC
C.H. Boehringer Sohn AG & Ko. KG
Abbvie Inc
Orion Pharma
GlaxoSmithKline plc
UCB S.A
F. Hoffmann-La Roche AG
Impax Laboratories, Inc.
Pzer, Inc.
In Chapter 5 and Chapter 7.3, based on types, the Parkinson Disease Drug market from 2017 to 2027 is primarily split into:
Decarboxylase Inhibitors
Dopamine Agonists
Monoamine Oxidase Type B (MAO-B) Inhibitor
Catechol-O-Methyltransferase (COMT) Inhibitors
Others
In Chapter 6 and Chapter 7.4, based on applications, the Parkinson Disease Drug market from 2017 to 2027 covers:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Parkinson Disease Drug market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Parkinson Disease Drug Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Parkinson Disease Drug market are covered in Chapter 9:
Lundbeck A/S
ACADIA Pharmaceuticals Inc.
Sanofi S.A.
Medtronic plc
Teva Pharmaceutical Industries Ltd.
Novartis AG
Merck & Co., Inc.
Homann-La Roche Ltd
Vertical Pharmaceuticals, LLC
C.H. Boehringer Sohn AG & Ko. KG
Abbvie Inc
Orion Pharma
GlaxoSmithKline plc
UCB S.A
F. Hoffmann-La Roche AG
Impax Laboratories, Inc.
Pzer, Inc.
In Chapter 5 and Chapter 7.3, based on types, the Parkinson Disease Drug market from 2017 to 2027 is primarily split into:
Decarboxylase Inhibitors
Dopamine Agonists
Monoamine Oxidase Type B (MAO-B) Inhibitor
Catechol-O-Methyltransferase (COMT) Inhibitors
Others
In Chapter 6 and Chapter 7.4, based on applications, the Parkinson Disease Drug market from 2017 to 2027 covers:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Parkinson Disease Drug market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Parkinson Disease Drug Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 PARKINSON DISEASE DRUG MARKET OVERVIEW
1.1 Product Overview and Scope of Parkinson Disease Drug Market
1.2 Parkinson Disease Drug Market Segment by Type
1.2.1 Global Parkinson Disease Drug Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Parkinson Disease Drug Market Segment by Application
1.3.1 Parkinson Disease Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Parkinson Disease Drug Market, Region Wise (2017-2027)
1.4.1 Global Parkinson Disease Drug Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.4.3 Europe Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.4.4 China Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.4.5 Japan Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.4.6 India Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.4.8 Latin America Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.5 Global Market Size of Parkinson Disease Drug (2017-2027)
1.5.1 Global Parkinson Disease Drug Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Parkinson Disease Drug Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Parkinson Disease Drug Market
2 INDUSTRY OUTLOOK
2.1 Parkinson Disease Drug Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Parkinson Disease Drug Market Drivers Analysis
2.4 Parkinson Disease Drug Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Parkinson Disease Drug Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Parkinson Disease Drug Industry Development
3 GLOBAL PARKINSON DISEASE DRUG MARKET LANDSCAPE BY PLAYER
3.1 Global Parkinson Disease Drug Sales Volume and Share by Player (2017-2022)
3.2 Global Parkinson Disease Drug Revenue and Market Share by Player (2017-2022)
3.3 Global Parkinson Disease Drug Average Price by Player (2017-2022)
3.4 Global Parkinson Disease Drug Gross Margin by Player (2017-2022)
3.5 Parkinson Disease Drug Market Competitive Situation and Trends
3.5.1 Parkinson Disease Drug Market Concentration Rate
3.5.2 Parkinson Disease Drug Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL PARKINSON DISEASE DRUG SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Parkinson Disease Drug Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Parkinson Disease Drug Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Parkinson Disease Drug Market Under COVID-19
4.5 Europe Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Parkinson Disease Drug Market Under COVID-19
4.6 China Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Parkinson Disease Drug Market Under COVID-19
4.7 Japan Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Parkinson Disease Drug Market Under COVID-19
4.8 India Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Parkinson Disease Drug Market Under COVID-19
4.9 Southeast Asia Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Parkinson Disease Drug Market Under COVID-19
4.10 Latin America Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Parkinson Disease Drug Market Under COVID-19
4.11 Middle East and Africa Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Parkinson Disease Drug Market Under COVID-19
5 GLOBAL PARKINSON DISEASE DRUG SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Parkinson Disease Drug Sales Volume and Market Share by Type (2017-2022)
5.2 Global Parkinson Disease Drug Revenue and Market Share by Type (2017-2022)
5.3 Global Parkinson Disease Drug Price by Type (2017-2022)
5.4 Global Parkinson Disease Drug Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Parkinson Disease Drug Sales Volume, Revenue and Growth Rate of Decarboxylase Inhibitors (2017-2022)
5.4.2 Global Parkinson Disease Drug Sales Volume, Revenue and Growth Rate of Dopamine Agonists (2017-2022)
5.4.3 Global Parkinson Disease Drug Sales Volume, Revenue and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2017-2022)
5.4.4 Global Parkinson Disease Drug Sales Volume, Revenue and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2017-2022)
5.4.5 Global Parkinson Disease Drug Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL PARKINSON DISEASE DRUG MARKET ANALYSIS BY APPLICATION
6.1 Global Parkinson Disease Drug Consumption and Market Share by Application (2017-2022)
6.2 Global Parkinson Disease Drug Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Parkinson Disease Drug Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Parkinson Disease Drug Consumption and Growth Rate of Hospital Pharmacy (2017-2022)
6.3.2 Global Parkinson Disease Drug Consumption and Growth Rate of Retail Pharmacy (2017-2022)
6.3.3 Global Parkinson Disease Drug Consumption and Growth Rate of Online Pharmacy (2017-2022)
7 GLOBAL PARKINSON DISEASE DRUG MARKET FORECAST (2022-2027)
7.1 Global Parkinson Disease Drug Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Parkinson Disease Drug Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Parkinson Disease Drug Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Parkinson Disease Drug Price and Trend Forecast (2022-2027)
7.2 Global Parkinson Disease Drug Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Parkinson Disease Drug Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Parkinson Disease Drug Revenue and Growth Rate of Decarboxylase Inhibitors (2022-2027)
7.3.2 Global Parkinson Disease Drug Revenue and Growth Rate of Dopamine Agonists (2022-2027)
7.3.3 Global Parkinson Disease Drug Revenue and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2022-2027)
7.3.4 Global Parkinson Disease Drug Revenue and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2022-2027)
7.3.5 Global Parkinson Disease Drug Revenue and Growth Rate of Others (2022-2027)
7.4 Global Parkinson Disease Drug Consumption Forecast by Application (2022-2027)
7.4.1 Global Parkinson Disease Drug Consumption Value and Growth Rate of Hospital Pharmacy(2022-2027)
7.4.2 Global Parkinson Disease Drug Consumption Value and Growth Rate of Retail Pharmacy(2022-2027)
7.4.3 Global Parkinson Disease Drug Consumption Value and Growth Rate of Online Pharmacy(2022-2027)
7.5 Parkinson Disease Drug Market Forecast Under COVID-19
8 PARKINSON DISEASE DRUG MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Parkinson Disease Drug Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Parkinson Disease Drug Analysis
8.6 Major Downstream Buyers of Parkinson Disease Drug Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Parkinson Disease Drug Industry
9 PLAYERS PROFILES
9.1 Lundbeck A/S
9.1.1 Lundbeck A/S Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.1.3 Lundbeck A/S Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 ACADIA Pharmaceuticals Inc.
9.2.1 ACADIA Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.2.3 ACADIA Pharmaceuticals Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Sanofi S.A.
9.3.1 Sanofi S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.3.3 Sanofi S.A. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Medtronic plc
9.4.1 Medtronic plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.4.3 Medtronic plc Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Teva Pharmaceutical Industries Ltd.
9.5.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.5.3 Teva Pharmaceutical Industries Ltd. Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Novartis AG
9.6.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.6.3 Novartis AG Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Merck & Co., Inc.
9.7.1 Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.7.3 Merck & Co., Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Homann-La Roche Ltd
9.8.1 Homann-La Roche Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.8.3 Homann-La Roche Ltd Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Vertical Pharmaceuticals, LLC
9.9.1 Vertical Pharmaceuticals, LLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.9.3 Vertical Pharmaceuticals, LLC Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 C.H. Boehringer Sohn AG & Ko. KG
9.10.1 C.H. Boehringer Sohn AG & Ko. KG Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.10.3 C.H. Boehringer Sohn AG & Ko. KG Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Abbvie Inc
9.11.1 Abbvie Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.11.3 Abbvie Inc Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Orion Pharma
9.12.1 Orion Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.12.3 Orion Pharma Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 GlaxoSmithKline plc
9.13.1 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.13.3 GlaxoSmithKline plc Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 UCB S.A
9.14.1 UCB S.A Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.14.3 UCB S.A Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 F. Hoffmann-La Roche AG
9.15.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.15.3 F. Hoffmann-La Roche AG Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Impax Laboratories, Inc.
9.16.1 Impax Laboratories, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.16.3 Impax Laboratories, Inc. Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Pzer, Inc.
9.17.1 Pzer, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.17.3 Pzer, Inc. Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Parkinson Disease Drug Market
1.2 Parkinson Disease Drug Market Segment by Type
1.2.1 Global Parkinson Disease Drug Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Parkinson Disease Drug Market Segment by Application
1.3.1 Parkinson Disease Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Parkinson Disease Drug Market, Region Wise (2017-2027)
1.4.1 Global Parkinson Disease Drug Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.4.3 Europe Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.4.4 China Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.4.5 Japan Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.4.6 India Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.4.8 Latin America Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Parkinson Disease Drug Market Status and Prospect (2017-2027)
1.5 Global Market Size of Parkinson Disease Drug (2017-2027)
1.5.1 Global Parkinson Disease Drug Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Parkinson Disease Drug Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Parkinson Disease Drug Market
2 INDUSTRY OUTLOOK
2.1 Parkinson Disease Drug Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Parkinson Disease Drug Market Drivers Analysis
2.4 Parkinson Disease Drug Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Parkinson Disease Drug Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Parkinson Disease Drug Industry Development
3 GLOBAL PARKINSON DISEASE DRUG MARKET LANDSCAPE BY PLAYER
3.1 Global Parkinson Disease Drug Sales Volume and Share by Player (2017-2022)
3.2 Global Parkinson Disease Drug Revenue and Market Share by Player (2017-2022)
3.3 Global Parkinson Disease Drug Average Price by Player (2017-2022)
3.4 Global Parkinson Disease Drug Gross Margin by Player (2017-2022)
3.5 Parkinson Disease Drug Market Competitive Situation and Trends
3.5.1 Parkinson Disease Drug Market Concentration Rate
3.5.2 Parkinson Disease Drug Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL PARKINSON DISEASE DRUG SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Parkinson Disease Drug Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Parkinson Disease Drug Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Parkinson Disease Drug Market Under COVID-19
4.5 Europe Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Parkinson Disease Drug Market Under COVID-19
4.6 China Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Parkinson Disease Drug Market Under COVID-19
4.7 Japan Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Parkinson Disease Drug Market Under COVID-19
4.8 India Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Parkinson Disease Drug Market Under COVID-19
4.9 Southeast Asia Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Parkinson Disease Drug Market Under COVID-19
4.10 Latin America Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Parkinson Disease Drug Market Under COVID-19
4.11 Middle East and Africa Parkinson Disease Drug Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Parkinson Disease Drug Market Under COVID-19
5 GLOBAL PARKINSON DISEASE DRUG SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Parkinson Disease Drug Sales Volume and Market Share by Type (2017-2022)
5.2 Global Parkinson Disease Drug Revenue and Market Share by Type (2017-2022)
5.3 Global Parkinson Disease Drug Price by Type (2017-2022)
5.4 Global Parkinson Disease Drug Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Parkinson Disease Drug Sales Volume, Revenue and Growth Rate of Decarboxylase Inhibitors (2017-2022)
5.4.2 Global Parkinson Disease Drug Sales Volume, Revenue and Growth Rate of Dopamine Agonists (2017-2022)
5.4.3 Global Parkinson Disease Drug Sales Volume, Revenue and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2017-2022)
5.4.4 Global Parkinson Disease Drug Sales Volume, Revenue and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2017-2022)
5.4.5 Global Parkinson Disease Drug Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL PARKINSON DISEASE DRUG MARKET ANALYSIS BY APPLICATION
6.1 Global Parkinson Disease Drug Consumption and Market Share by Application (2017-2022)
6.2 Global Parkinson Disease Drug Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Parkinson Disease Drug Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Parkinson Disease Drug Consumption and Growth Rate of Hospital Pharmacy (2017-2022)
6.3.2 Global Parkinson Disease Drug Consumption and Growth Rate of Retail Pharmacy (2017-2022)
6.3.3 Global Parkinson Disease Drug Consumption and Growth Rate of Online Pharmacy (2017-2022)
7 GLOBAL PARKINSON DISEASE DRUG MARKET FORECAST (2022-2027)
7.1 Global Parkinson Disease Drug Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Parkinson Disease Drug Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Parkinson Disease Drug Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Parkinson Disease Drug Price and Trend Forecast (2022-2027)
7.2 Global Parkinson Disease Drug Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Parkinson Disease Drug Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Parkinson Disease Drug Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Parkinson Disease Drug Revenue and Growth Rate of Decarboxylase Inhibitors (2022-2027)
7.3.2 Global Parkinson Disease Drug Revenue and Growth Rate of Dopamine Agonists (2022-2027)
7.3.3 Global Parkinson Disease Drug Revenue and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2022-2027)
7.3.4 Global Parkinson Disease Drug Revenue and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2022-2027)
7.3.5 Global Parkinson Disease Drug Revenue and Growth Rate of Others (2022-2027)
7.4 Global Parkinson Disease Drug Consumption Forecast by Application (2022-2027)
7.4.1 Global Parkinson Disease Drug Consumption Value and Growth Rate of Hospital Pharmacy(2022-2027)
7.4.2 Global Parkinson Disease Drug Consumption Value and Growth Rate of Retail Pharmacy(2022-2027)
7.4.3 Global Parkinson Disease Drug Consumption Value and Growth Rate of Online Pharmacy(2022-2027)
7.5 Parkinson Disease Drug Market Forecast Under COVID-19
8 PARKINSON DISEASE DRUG MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Parkinson Disease Drug Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Parkinson Disease Drug Analysis
8.6 Major Downstream Buyers of Parkinson Disease Drug Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Parkinson Disease Drug Industry
9 PLAYERS PROFILES
9.1 Lundbeck A/S
9.1.1 Lundbeck A/S Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.1.3 Lundbeck A/S Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 ACADIA Pharmaceuticals Inc.
9.2.1 ACADIA Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.2.3 ACADIA Pharmaceuticals Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Sanofi S.A.
9.3.1 Sanofi S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.3.3 Sanofi S.A. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Medtronic plc
9.4.1 Medtronic plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.4.3 Medtronic plc Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Teva Pharmaceutical Industries Ltd.
9.5.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.5.3 Teva Pharmaceutical Industries Ltd. Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Novartis AG
9.6.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.6.3 Novartis AG Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Merck & Co., Inc.
9.7.1 Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.7.3 Merck & Co., Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Homann-La Roche Ltd
9.8.1 Homann-La Roche Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.8.3 Homann-La Roche Ltd Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Vertical Pharmaceuticals, LLC
9.9.1 Vertical Pharmaceuticals, LLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.9.3 Vertical Pharmaceuticals, LLC Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 C.H. Boehringer Sohn AG & Ko. KG
9.10.1 C.H. Boehringer Sohn AG & Ko. KG Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.10.3 C.H. Boehringer Sohn AG & Ko. KG Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Abbvie Inc
9.11.1 Abbvie Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.11.3 Abbvie Inc Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Orion Pharma
9.12.1 Orion Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.12.3 Orion Pharma Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 GlaxoSmithKline plc
9.13.1 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.13.3 GlaxoSmithKline plc Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 UCB S.A
9.14.1 UCB S.A Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.14.3 UCB S.A Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 F. Hoffmann-La Roche AG
9.15.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.15.3 F. Hoffmann-La Roche AG Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Impax Laboratories, Inc.
9.16.1 Impax Laboratories, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.16.3 Impax Laboratories, Inc. Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Pzer, Inc.
9.17.1 Pzer, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Parkinson Disease Drug Product Profiles, Application and Specification
9.17.3 Pzer, Inc. Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Parkinson Disease Drug Product Picture
Table Global Parkinson Disease Drug Market Sales Volume and CAGR (%) Comparison by Type
Table Parkinson Disease Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Parkinson Disease Drug Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Parkinson Disease Drug Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Parkinson Disease Drug Industry Development
Table Global Parkinson Disease Drug Sales Volume by Player (2017-2022)
Table Global Parkinson Disease Drug Sales Volume Share by Player (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume Share by Player in 2021
Table Parkinson Disease Drug Revenue (Million USD) by Player (2017-2022)
Table Parkinson Disease Drug Revenue Market Share by Player (2017-2022)
Table Parkinson Disease Drug Price by Player (2017-2022)
Table Parkinson Disease Drug Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Parkinson Disease Drug Sales Volume, Region Wise (2017-2022)
Table Global Parkinson Disease Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume Market Share, Region Wise in 2021
Table Global Parkinson Disease Drug Revenue (Million USD), Region Wise (2017-2022)
Table Global Parkinson Disease Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Parkinson Disease Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Parkinson Disease Drug Revenue Market Share, Region Wise in 2021
Table Global Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Parkinson Disease Drug Sales Volume by Type (2017-2022)
Table Global Parkinson Disease Drug Sales Volume Market Share by Type (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume Market Share by Type in 2021
Table Global Parkinson Disease Drug Revenue (Million USD) by Type (2017-2022)
Table Global Parkinson Disease Drug Revenue Market Share by Type (2017-2022)
Figure Global Parkinson Disease Drug Revenue Market Share by Type in 2021
Table Parkinson Disease Drug Price by Type (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume and Growth Rate of Decarboxylase Inhibitors (2017-2022)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Decarboxylase Inhibitors (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume and Growth Rate of Dopamine Agonists (2017-2022)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Dopamine Agonists (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2017-2022)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2017-2022)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Parkinson Disease Drug Consumption by Application (2017-2022)
Table Global Parkinson Disease Drug Consumption Market Share by Application (2017-2022)
Table Global Parkinson Disease Drug Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Parkinson Disease Drug Consumption Revenue Market Share by Application (2017-2022)
Table Global Parkinson Disease Drug Consumption and Growth Rate of Hospital Pharmacy (2017-2022)
Table Global Parkinson Disease Drug Consumption and Growth Rate of Retail Pharmacy (2017-2022)
Table Global Parkinson Disease Drug Consumption and Growth Rate of Online Pharmacy (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Parkinson Disease Drug Price and Trend Forecast (2022-2027)
Figure USA Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Parkinson Disease Drug Market Sales Volume Forecast, by Type
Table Global Parkinson Disease Drug Sales Volume Market Share Forecast, by Type
Table Global Parkinson Disease Drug Market Revenue (Million USD) Forecast, by Type
Table Global Parkinson Disease Drug Revenue Market Share Forecast, by Type
Table Global Parkinson Disease Drug Price Forecast, by Type
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Decarboxylase Inhibitors (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Decarboxylase Inhibitors (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Dopamine Agonists (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Dopamine Agonists (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Parkinson Disease Drug Market Consumption Forecast, by Application
Table Global Parkinson Disease Drug Consumption Market Share Forecast, by Application
Table Global Parkinson Disease Drug Market Revenue (Million USD) Forecast, by Application
Table Global Parkinson Disease Drug Revenue Market Share Forecast, by Application
Figure Global Parkinson Disease Drug Consumption Value (Million USD) and Growth Rate of Hospital Pharmacy (2022-2027)
Figure Global Parkinson Disease Drug Consumption Value (Million USD) and Growth Rate of Retail Pharmacy (2022-2027)
Figure Global Parkinson Disease Drug Consumption Value (Million USD) and Growth Rate of Online Pharmacy (2022-2027)
Figure Parkinson Disease Drug Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Lundbeck A/S Profile
Table Lundbeck A/S Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Lundbeck A/S Parkinson Disease Drug Sales Volume and Growth Rate
Figure Lundbeck A/S Revenue (Million USD) Market Share 2017-2022
Table ACADIA Pharmaceuticals Inc. Profile
Table ACADIA Pharmaceuticals Inc. Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ACADIA Pharmaceuticals Inc. Parkinson Disease Drug Sales Volume and Growth Rate
Figure ACADIA Pharmaceuticals Inc. Revenue (Million USD) Market Share 2017-2022
Table Sanofi S.A. Profile
Table Sanofi S.A. Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi S.A. Parkinson Disease Drug Sales Volume and Growth Rate
Figure Sanofi S.A. Revenue (Million USD) Market Share 2017-2022
Table Medtronic plc Profile
Table Medtronic plc Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Medtronic plc Parkinson Disease Drug Sales Volume and Growth Rate
Figure Medtronic plc Revenue (Million USD) Market Share 2017-2022
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Pharmaceutical Industries Ltd. Parkinson Disease Drug Sales Volume and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Parkinson Disease Drug Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Merck & Co., Inc. Profile
Table Merck & Co., Inc. Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co., Inc. Parkinson Disease Drug Sales Volume and Growth Rate
Figure Merck & Co., Inc. Revenue (Million USD) Market Share 2017-2022
Table Homann-La Roche Ltd Profile
Table Homann-La Roche Ltd Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Homann-La Roche Ltd Parkinson Disease Drug Sales Volume and Growth Rate
Figure Homann-La Roche Ltd Revenue (Million USD) Market Share 2017-2022
Table Vertical Pharmaceuticals, LLC Profile
Table Vertical Pharmaceuticals, LLC Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Vertical Pharmaceuticals, LLC Parkinson Disease Drug Sales Volume and Growth Rate
Figure Vertical Pharmaceuticals, LLC Revenue (Million USD) Market Share 2017-2022
Table C.H. Boehringer Sohn AG & Ko. KG Profile
Table C.H. Boehringer Sohn AG & Ko. KG Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure C.H. Boehringer Sohn AG & Ko. KG Parkinson Disease Drug Sales Volume and Growth Rate
Figure C.H. Boehringer Sohn AG & Ko. KG Revenue (Million USD) Market Share 2017-2022
Table Abbvie Inc Profile
Table Abbvie Inc Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbvie Inc Parkinson Disease Drug Sales Volume and Growth Rate
Figure Abbvie Inc Revenue (Million USD) Market Share 2017-2022
Table Orion Pharma Profile
Table Orion Pharma Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Orion Pharma Parkinson Disease Drug Sales Volume and Growth Rate
Figure Orion Pharma Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline plc Parkinson Disease Drug Sales Volume and Growth Rate
Figure GlaxoSmithKline plc Revenue (Million USD) Market Share 2017-2022
Table UCB S.A Profile
Table UCB S.A Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure UCB S.A Parkinson Disease Drug Sales Volume and Growth Rate
Figure UCB S.A Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche AG Profile
Table F. Hoffmann-La Roche AG Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche AG Parkinson Disease Drug Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche AG Revenue (Million USD) Market Share 2017-2022
Table Impax Laboratories, Inc. Profile
Table Impax Laboratories, Inc. Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Impax Laboratories, Inc. Parkinson Disease Drug Sales Volume and Growth Rate
Figure Impax Laboratories, Inc. Revenue (Million USD) Market Share 2017-2022
Table Pzer, Inc. Profile
Table Pzer, Inc. Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pzer, Inc. Parkinson Disease Drug Sales Volume and Growth Rate
Figure Pzer, Inc. Revenue (Million USD) Market Share 2017-2022
Figure Parkinson Disease Drug Product Picture
Table Global Parkinson Disease Drug Market Sales Volume and CAGR (%) Comparison by Type
Table Parkinson Disease Drug Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Parkinson Disease Drug Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Parkinson Disease Drug Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Parkinson Disease Drug Industry Development
Table Global Parkinson Disease Drug Sales Volume by Player (2017-2022)
Table Global Parkinson Disease Drug Sales Volume Share by Player (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume Share by Player in 2021
Table Parkinson Disease Drug Revenue (Million USD) by Player (2017-2022)
Table Parkinson Disease Drug Revenue Market Share by Player (2017-2022)
Table Parkinson Disease Drug Price by Player (2017-2022)
Table Parkinson Disease Drug Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Parkinson Disease Drug Sales Volume, Region Wise (2017-2022)
Table Global Parkinson Disease Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume Market Share, Region Wise in 2021
Table Global Parkinson Disease Drug Revenue (Million USD), Region Wise (2017-2022)
Table Global Parkinson Disease Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Parkinson Disease Drug Revenue Market Share, Region Wise (2017-2022)
Figure Global Parkinson Disease Drug Revenue Market Share, Region Wise in 2021
Table Global Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Parkinson Disease Drug Sales Volume by Type (2017-2022)
Table Global Parkinson Disease Drug Sales Volume Market Share by Type (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume Market Share by Type in 2021
Table Global Parkinson Disease Drug Revenue (Million USD) by Type (2017-2022)
Table Global Parkinson Disease Drug Revenue Market Share by Type (2017-2022)
Figure Global Parkinson Disease Drug Revenue Market Share by Type in 2021
Table Parkinson Disease Drug Price by Type (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume and Growth Rate of Decarboxylase Inhibitors (2017-2022)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Decarboxylase Inhibitors (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume and Growth Rate of Dopamine Agonists (2017-2022)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Dopamine Agonists (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2017-2022)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2017-2022)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Parkinson Disease Drug Consumption by Application (2017-2022)
Table Global Parkinson Disease Drug Consumption Market Share by Application (2017-2022)
Table Global Parkinson Disease Drug Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Parkinson Disease Drug Consumption Revenue Market Share by Application (2017-2022)
Table Global Parkinson Disease Drug Consumption and Growth Rate of Hospital Pharmacy (2017-2022)
Table Global Parkinson Disease Drug Consumption and Growth Rate of Retail Pharmacy (2017-2022)
Table Global Parkinson Disease Drug Consumption and Growth Rate of Online Pharmacy (2017-2022)
Figure Global Parkinson Disease Drug Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Parkinson Disease Drug Price and Trend Forecast (2022-2027)
Figure USA Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Parkinson Disease Drug Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Parkinson Disease Drug Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Parkinson Disease Drug Market Sales Volume Forecast, by Type
Table Global Parkinson Disease Drug Sales Volume Market Share Forecast, by Type
Table Global Parkinson Disease Drug Market Revenue (Million USD) Forecast, by Type
Table Global Parkinson Disease Drug Revenue Market Share Forecast, by Type
Table Global Parkinson Disease Drug Price Forecast, by Type
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Decarboxylase Inhibitors (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Decarboxylase Inhibitors (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Dopamine Agonists (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Dopamine Agonists (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Parkinson Disease Drug Market Consumption Forecast, by Application
Table Global Parkinson Disease Drug Consumption Market Share Forecast, by Application
Table Global Parkinson Disease Drug Market Revenue (Million USD) Forecast, by Application
Table Global Parkinson Disease Drug Revenue Market Share Forecast, by Application
Figure Global Parkinson Disease Drug Consumption Value (Million USD) and Growth Rate of Hospital Pharmacy (2022-2027)
Figure Global Parkinson Disease Drug Consumption Value (Million USD) and Growth Rate of Retail Pharmacy (2022-2027)
Figure Global Parkinson Disease Drug Consumption Value (Million USD) and Growth Rate of Online Pharmacy (2022-2027)
Figure Parkinson Disease Drug Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Lundbeck A/S Profile
Table Lundbeck A/S Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Lundbeck A/S Parkinson Disease Drug Sales Volume and Growth Rate
Figure Lundbeck A/S Revenue (Million USD) Market Share 2017-2022
Table ACADIA Pharmaceuticals Inc. Profile
Table ACADIA Pharmaceuticals Inc. Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ACADIA Pharmaceuticals Inc. Parkinson Disease Drug Sales Volume and Growth Rate
Figure ACADIA Pharmaceuticals Inc. Revenue (Million USD) Market Share 2017-2022
Table Sanofi S.A. Profile
Table Sanofi S.A. Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi S.A. Parkinson Disease Drug Sales Volume and Growth Rate
Figure Sanofi S.A. Revenue (Million USD) Market Share 2017-2022
Table Medtronic plc Profile
Table Medtronic plc Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Medtronic plc Parkinson Disease Drug Sales Volume and Growth Rate
Figure Medtronic plc Revenue (Million USD) Market Share 2017-2022
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Pharmaceutical Industries Ltd. Parkinson Disease Drug Sales Volume and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Parkinson Disease Drug Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Merck & Co., Inc. Profile
Table Merck & Co., Inc. Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co., Inc. Parkinson Disease Drug Sales Volume and Growth Rate
Figure Merck & Co., Inc. Revenue (Million USD) Market Share 2017-2022
Table Homann-La Roche Ltd Profile
Table Homann-La Roche Ltd Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Homann-La Roche Ltd Parkinson Disease Drug Sales Volume and Growth Rate
Figure Homann-La Roche Ltd Revenue (Million USD) Market Share 2017-2022
Table Vertical Pharmaceuticals, LLC Profile
Table Vertical Pharmaceuticals, LLC Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Vertical Pharmaceuticals, LLC Parkinson Disease Drug Sales Volume and Growth Rate
Figure Vertical Pharmaceuticals, LLC Revenue (Million USD) Market Share 2017-2022
Table C.H. Boehringer Sohn AG & Ko. KG Profile
Table C.H. Boehringer Sohn AG & Ko. KG Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure C.H. Boehringer Sohn AG & Ko. KG Parkinson Disease Drug Sales Volume and Growth Rate
Figure C.H. Boehringer Sohn AG & Ko. KG Revenue (Million USD) Market Share 2017-2022
Table Abbvie Inc Profile
Table Abbvie Inc Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbvie Inc Parkinson Disease Drug Sales Volume and Growth Rate
Figure Abbvie Inc Revenue (Million USD) Market Share 2017-2022
Table Orion Pharma Profile
Table Orion Pharma Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Orion Pharma Parkinson Disease Drug Sales Volume and Growth Rate
Figure Orion Pharma Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline plc Parkinson Disease Drug Sales Volume and Growth Rate
Figure GlaxoSmithKline plc Revenue (Million USD) Market Share 2017-2022
Table UCB S.A Profile
Table UCB S.A Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure UCB S.A Parkinson Disease Drug Sales Volume and Growth Rate
Figure UCB S.A Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche AG Profile
Table F. Hoffmann-La Roche AG Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche AG Parkinson Disease Drug Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche AG Revenue (Million USD) Market Share 2017-2022
Table Impax Laboratories, Inc. Profile
Table Impax Laboratories, Inc. Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Impax Laboratories, Inc. Parkinson Disease Drug Sales Volume and Growth Rate
Figure Impax Laboratories, Inc. Revenue (Million USD) Market Share 2017-2022
Table Pzer, Inc. Profile
Table Pzer, Inc. Parkinson Disease Drug Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pzer, Inc. Parkinson Disease Drug Sales Volume and Growth Rate
Figure Pzer, Inc. Revenue (Million USD) Market Share 2017-2022
